4//SEC Filing
Schlienger Katia 4
Accession 0001104659-23-046890
CIK 0001760542other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 7:48 PM ET
Size
5.4 KB
Accession
0001104659-23-046890
Insider Transaction Report
Form 4
Schlienger Katia
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-04-14+184,000→ 184,000 totalExercise: $1.00Exp: 2033-04-14→ Common Stock (184,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on February 15, 2024, with the remainder vesting in 12 equal quarterly installments thereafter.
Documents
Issuer
HOOKIPA Pharma Inc.
CIK 0001760542
Entity typeother
Related Parties
1- filerCIK 0001974233
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 7:48 PM ET
- Size
- 5.4 KB